Amicus Therapeutics (FOLD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Amicus Therapeutics (FOLD) reported $126.67 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 34%. EPS of$ 0.06 for the same period compares to - $0.15 a year ago. The reported revenue represents a surprise of +4.90% over the Zacks Consensus Estimate of$ 120.76 million. With the consensus EPS estimate being $0.03, the EPS surprise was +100.00%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare t ...